Scottish Diabetes Industry Group

Group Description

This group sits within ABPI Scotland, with its membership coming from member companies who have an interest within the Diabetes disease area. The chair of the group is Joe Kerr.

Aims and objectives

Vision: SDIG aims to be an active partner with the Scottish Diabetes Group in the successful implementation of the Diabetes Action Plan for the benefit of patients across Scotland.

Aims: as an active partner:
· We welcome the opportunity to help develop solutions for the implementation of the Diabetes Action Plan
· We could utilise the combined business acumen and skills of the individuals / companies within the group
· We will be actively represented at all SDG meetings and the sub-groups
· The representative from SDIG will be empowered to act on behalf of the group

Aims: to develop and enhance trustworthiness:
· Focussing on prevention as well as treatment
· Implementing best practice as outlined in ‘A Common Understanding’ and the ABPI Code of Practice
· Outcomes will be developed through win/win/win thinking
· Delivering

Current activity

SDIG is currently involved in the following activities:
· Diabetes in Scotland Conference in partnership with The Scottish Government, NHSScotland and Diabetes UK Scotland
· Membership of the Scottish Diabetes Group and all the sub-groups
· Provision of Marketing Consultancy to SCI-DC

Future direction

SDIG will continue to be involved within the ongoing activities and also become involved in joint working solutions with the Scottish Diabetes Group which fit with the vision and aims of the group


AstraZeneca, Bristol-Myres Squibb, GSK, Johnson & Johnson/ Lifescan
Lilly UK, Merck Sharpe & Dohme, Merck Serono, Novo Nordisk, Pfizer, Sanofi-Aventis, Schering-Plough, Takeda

Contact Details

07974 444537
ABPI Scotland
Third Floor East
Crichton House
4 Crichton’s Close
Tel: 0870 890 4333